MetLife Investment Management LLC Sells 5,615 Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

MetLife Investment Management LLC decreased its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 17.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,902 shares of the company’s stock after selling 5,615 shares during the period. MetLife Investment Management LLC’s holdings in Aveanna Healthcare were worth $123,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. KLP Kapitalforvaltning AS bought a new stake in shares of Aveanna Healthcare during the fourth quarter valued at approximately $35,000. Catalyst Funds Management Pty Ltd boosted its stake in Aveanna Healthcare by 321.4% during the 4th quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock valued at $54,000 after purchasing an additional 9,000 shares during the last quarter. Sagespring Wealth Partners LLC bought a new stake in shares of Aveanna Healthcare in the 4th quarter worth $57,000. Arizona State Retirement System purchased a new position in shares of Aveanna Healthcare in the fourth quarter worth $64,000. Finally, Walleye Capital LLC bought a new position in shares of Aveanna Healthcare during the fourth quarter valued at $64,000. Institutional investors own 87.96% of the company’s stock.

Insider Activity at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the company’s stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares in the company, valued at approximately $8,172,496.74. This represents a 0.38 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Over the last ninety days, insiders sold 67,412 shares of company stock valued at $372,142. Corporate insiders own 7.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have issued reports on AVAH. Truist Financial lowered their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a research note on Friday, April 11th. UBS Group increased their price objective on shares of Aveanna Healthcare from $4.50 to $5.00 and gave the company a “sell” rating in a research report on Friday.

Aveanna Healthcare Stock Performance

Shares of Aveanna Healthcare stock opened at $5.42 on Friday. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $2.32 and a fifty-two week high of $6.19. The company has a market capitalization of $1.06 billion, a P/E ratio of -15.94 and a beta of 2.01. The company has a fifty day moving average of $4.84 and a 200 day moving average of $4.89.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.